Open AccessCost of Oncology Drugs in the Middle-Eastern Country of Lebanon: An Update (2014-2016)
Author(s) -
Fadia Elias,
Ibrahim R. Bou-Orm,
Salim M. Adib,
Selim Gebran,
Anthony Gebran,
Walid Ammar
Publication year - 2018
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.17.00179
Subject(s) - medicine , breast cancer , cancer , nivolumab , lung cancer , pembrolizumab , trastuzumab , family medicine , cancer drugs , biosimilar , oncology , immunotherapy
This study aims to evaluate trends in the increasing costs of oncology drugs procured by the Lebanese Ministry of Public Health (MOPH) between 2014 and 2016 and to assess the impact of the introduction in mid-2015 of new immunotherapy drugs for the treatment of lung cancer on the overall and specific costs of that treatment.